Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free-Energy Perturbation (FEP)
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free-Energy Perturbation (FEP)
Authors
Keywords
-
Journal
ChemMedChem
Volume 11, Issue 2, Pages 217-233
Publisher
Wiley
Online
2015-09-18
DOI
10.1002/cmdc.201500333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
- (2015) Lingle Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase
- (2014) Kevin S. Currie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Type-II Inhibitors Using Kinase Structures
- (2012) Frank Lovering et al. Chemical Biology & Drug Design
- The status of fostamatinib in the treatment of rheumatoid arthritis
- (2012) Jorge Morales-Torres Expert Review of Clinical Immunology
- Biophysical Limits of Protein–Ligand Binding
- (2012) Richard D. Smith et al. Journal of Chemical Information and Modeling
- Rational Design of Highly Selective Spleen Tyrosine Kinase Inhibitors
- (2012) Matthew C. Lucas et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Syk kinase as a therapeutic target in leukemia and lymphoma
- (2011) Dimitar G Efremov et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
- (2011) W. Patrick Walters et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Src, Syk, and Tec family kinases: Distinct types of molecular switches
- (2010) J. Michael Bradshaw CELLULAR SIGNALLING
- An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola
- (2010) William J Moore et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Therapeutic Targeting of Syk in Autoimmune Diabetes
- (2010) L. Colonna et al. JOURNAL OF IMMUNOLOGY
- Syk and pTyr'd: Signaling through the B cell antigen receptor
- (2009) Robert L. Geahlen BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The tyrosine kinase network regulating mast cell activation
- (2009) Alasdair M. Gilfillan et al. IMMUNOLOGICAL REVIEWS
- Molecular Mechanism of the Syk Activation Switch
- (2008) Emily Tsang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Perspective on Free-Energy Perturbation Calculations for Chemical Equilibria
- (2008) William L. Jorgensen et al. Journal of Chemical Theory and Computation
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started